IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q4 2019 Holdings

Filed 2020-02-12 | 33 holdings | $11.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$2.9M33,78124.8%
Centene Corp(CNC)COM15135B101$2.8M44,42624.2%
Bio-Rad Laboratories(BIO)COM090572207$2.4M6,35120.4%
Abbvie Inc(ABBV)COM00287Y109$1.7M18,92114.5%
Ascendis Pharma A/S(ASND)ADR04351P101$911.0K6,5477.9%
Cytokinetics Inc(CYTK)COM23282W605$904.0K85,1727.8%
Baxter International Inc(BAX)COM071813109$4.4K52,1920.0%
Guardant Health Inc(GH)COM40131M109$2.8K35,2360.0%
Insmed Inc(INSM)COM457669307$2.7K113,8750.0%
Mylan NVCOMN59465109$2.7K132,8550.0%
PTC Therapeutics(PTCT)COM69366J200$2.7K55,4080.0%
Tandem Diabetes Care Inc(TNDM)COM875372203$2.6K43,5590.0%
Arena Pharmaceuticals Inc(ARNAEUR)COM040047607$1.9K42,6880.0%
Unitedhealth Group Inc(UNH)COM91324P102$1.9K6,4140.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$1.7K4,5840.0%
Myokardia IncCOM62857M105$1.7K23,0230.0%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$1.5K62,5070.0%
Dermira Inc(DERMEUR)COM24983L104$1.4K81,1270.0%
Exicure Inc(XCUR)COM30205M101$1.4K500,0000.0%
Esperion Therapeutics Inc(ESPR)COM29664W105$1.4K22,8720.0%
Gilead Sciences Inc(GILD)COM375558103$1.4K20,7910.0%
Bristol-Myers Squibb-Cvr(BMY-R)RTS110122157$1.3K415,9310.0%
Momenta Pharmaceuticals Inc(MNTA)COM60877T100$1.2K62,5850.0%
Ehealth Inc(EHTH)COM28238P109$1.2K15,0040.0%
Portola Pharmaceuticals IncCOM737010108$1.2K49,4310.0%
Twist Bioscience Corp(TWST)COM90184D100$1.1K54,3340.0%
Viewray Inc(VRAYQ)COM92672L107$1.1K256,2050.0%
Nucana PLCADR67022C106$975159,8980.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$96298,7180.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$8966,9500.0%
Varian Medical Systems Inc(VAREUR)COM92220P105$8435,9340.0%
Marinus Pharmaceuticals IncCOM56854Q101$766354,8530.0%
Apellis Pharmaceuticals(APLS)COM03753U106$65521,3800.0%